Smith & Nephew plc (NYSE:SNN) Given Average Rating of “Moderate Buy” by Brokerages

Smith & Nephew plc (NYSE:SNN) has earned a consensus rating of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company.

Several brokerages have recently issued reports on SNN. Deutsche Bank Aktiengesellschaft initiated coverage on Smith & Nephew in a report on Wednesday, July 24th. They issued a “buy” rating for the company. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th.

Hedge Funds Weigh In On Smith & Nephew

Institutional investors and hedge funds have recently modified their holdings of the business. Argonautica Private Wealth Management Inc. increased its stake in Smith & Nephew by 6.3% during the 2nd quarter. Argonautica Private Wealth Management Inc. now owns 10,244 shares of the medical equipment provider’s stock worth $254,000 after buying an additional 605 shares in the last quarter. Inspire Advisors LLC increased its stake in Smith & Nephew by 3.0% during the 2nd quarter. Inspire Advisors LLC now owns 22,286 shares of the medical equipment provider’s stock worth $552,000 after buying an additional 639 shares in the last quarter. Rhumbline Advisers increased its stake in Smith & Nephew by 8.6% during the 2nd quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock worth $257,000 after buying an additional 819 shares in the last quarter. Legacy Wealth Asset Management LLC increased its stake in Smith & Nephew by 6.0% during the 1st quarter. Legacy Wealth Asset Management LLC now owns 16,022 shares of the medical equipment provider’s stock worth $406,000 after buying an additional 903 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in Smith & Nephew by 13.8% during the 1st quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock worth $244,000 after buying an additional 1,165 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Stock Performance

Shares of SNN stock opened at $29.56 on Tuesday. The stock has a market cap of $12.92 billion, a PE ratio of 14.21, a price-to-earnings-growth ratio of 1.25 and a beta of 0.82. The business has a 50-day simple moving average of $30.37 and a 200-day simple moving average of $27.53. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $31.72.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.